Home > Education : ACCC Continuing Education
Welcome to the ACCC Blackboard! Our e–learning environment is designed to provide easy access to an array of timely oncology-related continuing education programs.
The ACCC Blackboard includes programming from educational companies, covering a range of topics for nurses, pharmacists, and physicians. Formats vary from slide shows to virtual lectures to newsletters. Upon completion of the activity, simply submit your learning assessment and/or evaluation form online, as explained by the course provider.
This program describes new recommendations regarding multidisciplinary approaches to non-small cell lung cancer (NSCLC) classification as well as evidence-based strategies to optimize first-line therapy for the individual patient with NSCLC based on the results of pathologic analyses, the performance status of the patient, and the efficacy and safety of available cytotoxic and biologic agents. These factors, as well as the disease response to first-line therapy, form the basis for decision making regarding maintenance therapy.
1.0 CME
This learning activity reviews the evidence base for multiple myeloma treatment regimens; the factors influencing the selection and timing of induction therapy, maintenance therapy, and transplantation; and strategies for managing patients with treatment-related toxicities.
1.0 CME
Lymphoid Leukemia Virtual Education Summit:
Conversations and Controversies in Hematologic Malignancies and Hematology
Interactive Video CME at No Cost:
LIVE: Wednesday, September 7, 12:30 – 6:00 PM EDT.
ON DEMAND: Until March 6, 2012.
This activity has been approved for 4.5 AMA PRA Category 1 Credits™.
Sign-Up Now at Oncology Care Live
Oncology Care Live is an online oncology congress featuring video case studies, roundtables and panel discussions. Oncology Care Live enables hematologist/oncologists, medical oncologists, and other healthcare professionals to stay current with recent advances in cancer patient care from the ease of any computer at no cost.
Faculty includes respected oncologists from institutions such as the Mayo Clinic, Memorial Sloan-Kettering Cancer Center, Penn Presbyterian Medical Center, Roswell Park Cancer Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and the University of Chicago Comprehensive Cancer Center.
Activity Directors: Carol Ann Huff, MD, and Judith Karp, MD, Johns Hopkins University School of Medicine
Session Topics:
- The State of Cancer Care in the Coming Decade
- Multiple Myeloma
- CLL—Treatment of High–Risk Disease in a Young Patient
- New Agents in NHL: Where do They Fit in the Treatment Paradigm?
- Debate: ALL in Adolescents and Young Adults—Is It a Different Disease?
INTRODUCING PCE ONCOLOGY! Education designed exclusively for the NP/PA oncology specialist.
Practicing Clinicians Exchange (PCE) is dedicated to providing nurse practitioners and physician assistants who specialize in oncology with continuing education tailored to their clinical practice. Until now, there have been no educational initiatives designed specifically for NPs and PAs who specialize in oncology. NPs and PAs in oncology are not only fulfilling traditional roles in patient counseling and supportive care, but are also taking on more advanced clinical activities, such as writing chemotherapy orders and assisting with new patient consults. The mission of PCE Oncology is to provide high-level learning to NPs and PAs in oncology through live, enduring, and online activities.
Overcoming Key Challenges to Lung Cancer Clinical Trial Recruitment and Retention
A Live Satellite Broadcast, Webcast, and Teleconference
Register now at www.thecbce.com/lungtrials.
Chair: Joan Schiller, MD
Tuesday, June 14, 2011
12:00 PM-1:00 PM ET
Broadcast to Re-air at 1:00 PM, 2:00 PM, and 3:00 PM ET. Please adjust to your time zone.
Although it is recognized that clinical trials are critical to the development of new treatment regimens that are needed to improve the treatment of patients with lung cancer, only 14% of patients with lung cancer are aware of clinical trials as a treatment option, and fewer than 10% of patients with lung cancer are enrolled in clinical trials. Commitment from clinical researchers, patient advocates, government agencies, and private industries is needed to improve clinical trial enrollment and retention through building relationships, strengthening communication, educating patients and caregivers, streamlining protocols, and developing clinical trials that address paramount needs in patients with lung cancer.
This activity will illustrate the importance of clinical trial enrollment and retention in advancing patient care, explain potential barriers that impact enrollment in clinical trials, and discuss strategies that can be used to overcome challenges in recruiting and retaining participants in lung cancer clinical trials.
This activity has been approved for AMA PRA Category 1 Credit™.
www.thecbce.com/lungtrials
Targeting the Proteasome in Multiple Myeloma—A Cancer Talk Live Broadcast℠
Archived Broadcast Available Now!
Targeting the Proteasome in Multiple Myeloma—A Cancer Talk Live Broadcast℠ focused on the biological basis for proteasome inhibitors in MM patients, and compared and contrasted both biochemical and clinical properties of proteasome inhibitors. The broadcast culminated in a lively panel discussion of MM cases and the clinical implications and future directions of proteasome inhibition in myeloma. Original broadcast date: March 31, 2011.
Designed for community-based hematologists, hematologist-oncologists, medical oncologists, oncology specialty pharmacists, and mid-level practitioners caring for patients with multiple myeloma.
Supported by an educational grant from Onyx Pharmaceuticals, Inc.
This activity is sponsored by Educational Concepts Group.
Click here to register and view broadcast.
iPointOfCare for Non–Small Cell Lung Cancer
A Web–based tool
- iPointOfCare brings peer-reviewed articles and expert opinion about NSCLC as close as your computer or web-enabled mobile device.
- iPOC's Conference Highlights section lets you review the proceedings of important cancer meetings you may not have been able to attend.
- Save articles and abstracts for future reference and share with colleagues. Earn CME credit, too. Find out more!
iPointOfCare for Non–Small Cell Lung Cancer is sponsored by DIME.
iPointOfCare for Non–Small Cell Lung Cancer is funded through an educational grant from Bristol-Myers Squibb.
iPointOfCare for Non–Small Cell Lung Cancer is supported by an educational grant from Genentech BioOncology & OSI Oncology.
DIME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 Credit™.
This new online newsletter provides timely information on important changes in clinical practice as well as key recent literature and research that will advance the care of patients in the community-based setting. In an interactive format, the newsletter offers concise reviews of practical research that is likely to enter the clinical armamentarium within the year, summarizes key clinical and practice-related publications, reviews a representative case to highlight evidence-based decision-making, and provides links to helpful guidelines, organizations, and websites. This activity is relevant for all clinical oncologists, but especially those in non-urban, non-academic settings.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of Albert Einstein College of Medicine, Montefiore Medical Center, and In 2 MedEd, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
This is made possible by an unrestricted educational grant from Pfizer, Inc.
Advanced Renal Cell Carcinoma: Molecular Pathways and Clinical Applications
Schedule this free CME activity at your office. To have a speaker present at your office, please call 1.866.832.7178, or click here for a meeting request form and details. This program is intended for community-based physicians and nurses involved in the treatment of patients with advanced RCC.
Offered by SCEPTER and Quintiles.
Unifying Practice Patterns Among Academic and Community Clinicians: Focus on Myeloma
This online, video-based CE program was developed from a live satellite symposium preceding the 51st ASH Annual Meeting. Five academic and community faculty pairs present real-life case challenges in multiple myeloma focusing on relapsed/refractory, transplant as salvage therapy, elderly newly diagnosed patients, transplant-eligible patients, and maintenance.
Offered by ManagingMyeloma.com and MediCom Worldwide, Inc.
The Mastery of Myeloma Course
This series of CE case-based activities, adapted from the Mastery of Myeloma Course held in November 2009, will address appropriate practices in the multidisciplinary management of multiple myeloma for physicians, nurses, pharmacists, and physician assistants.
Offered by ManagingMyeloma.com and MediCom Worldwide, Inc.
Translating Multiple Myeloma Data Into Clinical Practice E–Newsletter Series—Includes Expert Opinion
An e-newsletter series that summarizes important publications regarding the treatment of multiple myeloma (MM) and explains how to translate the data into clinical practice. These activities are designed through expert opinion for oncologists and nurse practitioners who provide care for patients with MM.
Supported by an educational grant from Celgene Corporation.
Hematology/Oncology Tumor Board: Challenges in Nursing Management of Emerging Therapies for Hematologic Malignancies
A virtual lecture of the live satellite symposium held in conjunction with the 34th Annual Congress of the Oncology Nursing Society on May 2, 2009 in San Antonio, Texas. This activity is designed for nurses and nurse practitioners who provide care for patients with hematologic malignancies. Supported by an educational grant from Celgene Corporation.
Sponsored by Meniscus Educational Institute
Therapeutic Advances in the Treatment and Management of Multiple Myeloma
This webcast is intended for hematologists, oncologists, nurses, pharmacists, and other healthcare professionals interested in the safety and efficacy of novel agents in the treatment of patients with newly diagnosed and relapsed/refractory multiple myeloma. The activity also includes a discussion of the factors impacting the choice and sequence of therapy.
This activity is valid for physicians, pharmacists and nurses and is designated for one credit or contact hour. All accreditation information is included in the participant package.
Sponsored by TWL Global Underwriting
If you have any comments about ACCC Blackboard, about any aspect of the available programming, or if you want to suggest a topic for consideration or report a problem —
we would like to hear from you.
Disclaimer:
Notwithstanding any language to the contrary, nothing contained on the Association of Community Cancer Centers (ACCC) CE Blackboard constitutes, nor is intended to constitute, an offer, inducement, promise, or contract of any kind. The data contained herein are for informational purposes only and are not represented to be error free. Any links to non-ACCC information are provided as a courtesy. They are not intended to constitute, nor do they constitute, an endorsement of the linked materials by ACCC. The information presented reflects the views of the faculty/authors of the medical education organization(s) only and are not those of ACCC. Without limiting the foregoing, ACCC makes no representations or warranties about the accuracy, reliability, completeness, currentness, or timeliness of the content, software, text, graphics, links, or communications provided on or through the use of the ACCC CE Blackboard. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
ACCC's MyNetwork
Facebook
LinkedIn
Twitter
ACCC Vision Channel